The average of price targets set by Wall Street analysts indicates a potential upside of 104.5% in Rapport Therapeutics, Inc. (RAPP). While the effectiveness of this highly sought-after metric is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback